American Journal of Obstetrics & Gynecology Mfm最新文献

{"title":"Letter to the Editor re: Quantifying placenta accreta spectrum severity and its associated blood loss: a novel transvaginal ultrasound scoring system.","authors":"Rozi Aditya Aryananda, Theophilus Adu-Bredu, Hans Duvekot","doi":"10.1016/j.ajogmf.2025.101721","DOIUrl":"10.1016/j.ajogmf.2025.101721","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101721"},"PeriodicalIF":3.8,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter in reply to: breast stimulation vs low dose oxytocin for labor augmentation in women with a previous cesarean delivery, a randomized controlled trial.","authors":"Raneen Abu Shqara, Lior Lowenstein, Maya Frank Wolf","doi":"10.1016/j.ajogmf.2025.101718","DOIUrl":"10.1016/j.ajogmf.2025.101718","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101718"},"PeriodicalIF":3.8,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antenatal dexamethasone vs betamethasone on glycemic control in mild gestational diabetes: a randomized clinical trial","authors":"Fathimath Shamaa Shareef MObGyn, Jesrine Hong MObGyn, Rahmah Saaid MObGyn, Mukhri Hamdan MObGyn, PhD, Siti Zawiah Omar MObGyn, Peng Chiong Tan PhD","doi":"10.1016/j.ajogmf.2025.101715","DOIUrl":"10.1016/j.ajogmf.2025.101715","url":null,"abstract":"<div><h3>BACKGROUND</h3><div>Preterm birth and gestational diabetes mellitus are common complications of pregnancy. A widely known side effect of antenatal corticosteroids on fetal maturity in preterm births is maternal hyperglycemia. The choice of antenatal corticosteroid regimens between dexamethasone and betamethasone highly depends on local availability and cost, as current but inconclusive evidence shows similar neonatal outcomes for both regimes.</div></div><div><h3>OBJECTIVE</h3><div>This study aimed to compare four 6.0-mg doses of antenatal dexamethasone administered 12 hours apart vs two 11.4-mg doses of antenatal betamethasone administered 24 hours apart in medical nutrition therapy–controlled gestational diabetes mellitus cases on maternal glycemic response for up to 3 consecutive days after administration.</div></div><div><h3>STUDY DESIGN</h3><div>This was a randomized controlled clinical trial conducted between February 2021 and August 2023 at a tertiary university hospital in Malaysia. Pregnant participants with diet-controlled gestational diabetes mellitus and prescribed antenatal corticosteroid were randomized to either four 6.0-mg doses of dexamethasone administered 12 hours apart or two 11.4-mg doses of betamethasone administered 24 hours apart. Self-monitoring of capillary blood glucose level (6 points per 24 hours: 2 hours before and after a meal for the 3 main meals) was started after the first dose of allocated antenatal corticosteroid. Hyperglycemia was defined as a fasting or premeal glucose level of ≥5.3 mmol/L (≤95 mg/dL) or a 2-hour postmeal glucose level of ≥6.7 mmol/L (120 mg/dL). The primary outcomes were number of hyperglycemic episodes within the first and second 24 hours after antenatal corticosteroid administration. Analyses were performed using the <em>t</em> test, Mann-Whitney <em>U</em> test, and chi-square test, as appropriate.</div></div><div><h3>RESULTS</h3><div>The median hyperglycemic episodes were similar between the dexamethasone group and the betamethasone group: 4.0 (interquartile range, 2.3–5.0) vs 4.0 (interquartile range, 3.5–5.0), respectively, on day 1 (<em>P</em>=.168), 4.0 (interquartile range, 3.0–5.0) vs 5.0 (interquartile range, 4.0–5.0), respectively, on day 2 (<em>P</em>=.002), and 1.0 (interquartile range, 0.0–2.0) vs 2.0 (interquartile range, 1.0–3.0), respectively, on day 3 (<em>P</em><.001). In addition, the median blood glucose levels were significantly lower in the dexamethasone group than in the betamethasone group on days 1, 2, and 3 (day 1: 6.3 [interquartile range, 5.8–7.0] vs 6.7 [interquartile range, 6.3–7.0], respectively; <em>P</em>=.016; day 2: 6.4 [interquartile range, 6.0–6.9] vs 6.7 [interquartile range, 6.3–7.2], respectively; <em>P</em>=.001; day 3: 5.2 [interquartile range, 4.8–5.5] vs 5.7 [interquartile range, 5.4–6.0], respectively; <em>P</em><.001). The mean blood glucose levels were higher in the betamethasone group than in the dexamethasone group on day 1 to","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 8","pages":"Article 101715"},"PeriodicalIF":3.8,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum to ‘High- vs low-dose oxytocin regimens for labor augmentation: a systematic review and meta-analysis’. American Journal of Obstetrics & Gynecology MFM/ Volume 7 Issue 2 (February 2025)/ 101604","authors":"Teresa C. Logue MD, MPH , Fabrizio Zullo MD , Fiamma van Biema MA , Moeun Son MD, MSCI , Lauren London MD , Sneha Paranandi MD , Anthony C. Sciscione DO , Giuseppe Rizzo MD , Daniele Di Mascio MD , Suneet P. Chauhan MD, Hon DSc","doi":"10.1016/j.ajogmf.2025.101685","DOIUrl":"10.1016/j.ajogmf.2025.101685","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 7","pages":"Article 101685"},"PeriodicalIF":3.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Additional Mechanical Force Necessary for Foley-Induced Cervical Ripening?","authors":"Maryam Abdelkarim, Siobhan Quenby, Joshua Odendaal","doi":"10.1016/j.ajogmf.2025.101707","DOIUrl":"10.1016/j.ajogmf.2025.101707","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101707"},"PeriodicalIF":3.8,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pregnancy outcomes following diabetic ketoacidosis: a systematic review","authors":"Gabriella D. Cozzi-Glaser MD ,&nbsp;Allison M. Davis MD ,&nbsp;Megan Bell MLIS, AHIP ,&nbsp;Ashley N. Battarbee MD, MSCR","doi":"10.1016/j.ajogmf.2025.101711","DOIUrl":"10.1016/j.ajogmf.2025.101711","url":null,"abstract":"<div><h3>OBJECTIVE</h3><div>The primary objective of this systematic review was to evaluate pregnancy outcomes following at least 1 episode of diabetic ketoacidosis in patients with gestational or pregestational diabetes mellitus.</div></div><div><h3>DATA SOURCES</h3><div>An electronic search of English-language publications in PubMed, Embase, Web of Science, and Google Scholar covered the period from January 1990 to June 2023.</div></div><div><h3>STUDY ELIGIBILITY CRITERIA</h3><div>The eligibility criteria included randomized clinical trials or observational studies (ie, cohort studies, case–control studies) of patients with diabetic ketoacidosis in pregnancy and evaluation of maternal or neonatal outcomes. Systematic reviews, expert reviews, case reports, case series, animal studies, non–peer-reviewed publications, abstract-only publications, and publications without available full-text articles were excluded.</div></div><div><h3>METHODS</h3><div>Each study was reviewed in detail by 2 coauthors. The quality of each study was appraised using the Cochrane RoB 2 risk-of-bias tool for randomized trials and the JBI Critical Appraisal tools for cohort and case–control analyses.</div></div><div><h3>RESULTS</h3><div>Of the 1313 studies identified through data search, 7 met the final inclusion criteria. Study heterogeneity precluded any meta-analysis. High rates of adverse maternal and neonatal outcomes were found among those with at least 1 episode of diabetic ketoacidosis in pregnancy, with the following incidence rates: 7% to 35% for stillbirth, 49% to 64% for cesarean delivery, 25% to 83% for preterm birth, and 40% to 65% for neonatal intensive care unit admission. The most recent studies note a stillbirth rate of 7% to 31%, with most analyses finding a rate &lt;17%.</div></div><div><h3>CONCLUSION</h3><div>There is a paucity of well-designed studies evaluating pregnancy outcomes associated with diabetic ketoacidosis. Maternal and fetal outcomes following diabetic ketoacidosis remain poor, although stillbirth may be incrementally decreasing over time. As diabetes care and diabetic ketoacidosis management advance, future retrospective and prospective analyses should evaluate the management and outcomes of diabetic ketoacidosis.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 8","pages":"Article 101711"},"PeriodicalIF":3.8,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144188232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to Editor Reply to : Regarding \"Tugging the Foley catheter balloon every three hours in induction of labor after one previous cesarean: a randomized controlled trial\".","authors":"Mukhri Hamdan, Thai Ying Wong, Peng Chiong Tan","doi":"10.1016/j.ajogmf.2025.101708","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101708","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101708"},"PeriodicalIF":3.8,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144188209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Maternal cholesterol matters: it is time for routine monitoring","authors":"Amanda A. de Oliveira PhD ,&nbsp;Christy-Lynn M. Cooke MD, PhD ,&nbsp;Sandra T. Davidge PhD","doi":"10.1016/j.ajogmf.2025.101684","DOIUrl":"10.1016/j.ajogmf.2025.101684","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 7","pages":"Article 101684"},"PeriodicalIF":3.8,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144147552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing a novel patient-centered definition of severe maternal morbidity","authors":"Adina R. Kern-Goldberger MD, MPH, MSCE ,&nbsp;Lauren E. Callans MD ,&nbsp;Rebecca F. Hamm MD, MSCE ,&nbsp;Lisa D. Levine MD, MSCE","doi":"10.1016/j.ajogmf.2025.101706","DOIUrl":"10.1016/j.ajogmf.2025.101706","url":null,"abstract":"<div><h3>Background</h3><div>Defining, preventing, and evaluating severe maternal morbidity (SMM) has become an important component of obstetric care delivery, but existing frameworks for SMM do not account for how patients perceive and experience morbidity.</div></div><div><h3>Objective</h3><div>This study evaluated patient values and perceptions related to maternal pregnancy complications with the goal of devising a patient-centered maternal morbidity composite.</div></div><div><h3>Study Design</h3><div>This 2-part sequential qualitative to quantitative mixed-methods study first involved semi-structured interviews of postpartum patients recruited from an urban, academic hospital prior to discharge from the delivery admission with purposive sampling by race and mode of delivery. Qualitative data around patient-perceived adverse maternal events were analyzed thematically. These themes were used to develop a survey which prompted ranking the maternal complications derived from these interview data as well as the SMM indicators defined by the Centers for Disease Control and Prevention (CDC) on a scale from 1 (“no big deal”) - 5 (“worst thing imaginable”). Responses were compared in bivariate analyses among patients who did and did not personally experience an expanded maternal morbidity composite inclusive of SMM as well as postpartum hemorrhage, re-operation, intensive care unit admission, and endometritis/post-operative infection. All postpartum patients were eligible to participate and recruited participants completed the survey prior to discharge.</div></div><div><h3>Results</h3><div>18 patients participated in the semi-structured interviews with 9 themes identified distinct from established SMM criteria. 501 patients then completed the survey over 5 months (6/2022 to 11/2022). 60.7% of participants were Black, 6.5% were Hispanic, median maternal age was 31 [IQR 26−34], 40.6% underwent cesarean delivery, 6% experienced a postpartum hemorrhage, and 1.6% (N=8) experienced non-transfusion SMM as defined by the CDC. The 3 maternal morbidity outcomes ranked by patients as “worst” were stroke/seizure, hysterectomy, and heart failure. Other notable findings included that 66.3% of patients ranked severe postpartum depression as a 4 or 5, higher than hemorrhage, transfusion, and long-term physical disability. There were no significant differences in scoring of maternal morbidity types among patients who did and did not personally experience morbidity<strong>.</strong></div></div><div><h3>Conclusion</h3><div>Adverse maternal outcomes important to patients do not correlate directly with established SMM composites. Novel definitions of maternal morbidity incorporating expanded indicators such as severe depression could fuel a patient-centered approach to evaluating and mitigating SMM in research and clinical care.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 8","pages":"Article 101706"},"PeriodicalIF":3.8,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144162670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemoglobin A1c among patients without diabetes and risk of large for gestational age neonates.","authors":"Ximena A VAN Tienhoven, Kelly Zafman, Whitney R Bender, Celeste Durnwald","doi":"10.1016/j.ajogmf.2025.101710","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101710","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101710"},"PeriodicalIF":3.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}